Compile Data Set for Download or QSAR
Report error Found 27 Enz. Inhib. hit(s) with all data for entry = 5555
TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369192BDBM369192(6-(2-Aminoanilino)-3H-1,3-benzothiazol-2-one | US1...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369207BDBM369207(3,3-Difluoro-5-(2-isopropylbenzimidazol-1-yl)indol...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369213BDBM369213(5-(2-Isopropylbenzimidazol-1-yl)-1,3-dihydropyrrol...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369208BDBM369208(6-(4-Hydroxyisoindoline-2-carbonyl)-3H-1,3-benzoxa...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369190BDBM369190(2-Isopropyl-N-methyl-1-(2-oxoindolin-6-yl)benzimid...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369191BDBM369191(2-Isopropyl-N-methyl-1-(2-oxoindolin-5-yl)benzimid...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 368972BDBM368972(N-(2-Oxo-3H-1,3-benzoxazol-6-yl)benzamide | US1252...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369199BDBM369199(6-(Indoline-1-carbonyl)-3H-1,3-benzoxazol-2-one | ...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369198BDBM369198(N-(1-Acetyl-4-piperidyl)-2-oxo-3H-1,3-benzoxazole-...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 368996BDBM368996(N-(2-Oxoindolin-5-yl)furan-2-carboxamide | US12528...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369205BDBM369205(N-(1-Acetyl-4-piperidyl)-2-oxo-3H-oxazolo[4,5-b]py...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369212BDBM369212(2-Isopropyl-A-methyl-1-(2-oxo-1,3-dihydropyrrolo[2...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369194BDBM369194(6-(2-Aminoanilino)-3H-1,3-benzoxazol-2-one | US125...)
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369206BDBM369206(5-(Indoline-1-carbonyl)-1,3-dihydropyrrolo[2,3-b]p...)
Affinity DataKd:  13nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369189BDBM369189(2-(2-Methylphenoxy)-N-(2-oxo-3H-1,3-benzothiazol-6...)
Affinity DataKd:  14nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369209BDBM369209(6-(4-Nitroisoindoline-2-carbonyl)-3H-1,3-benzoxazo...)
Affinity DataKd:  14nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369203BDBM369203(5-(Indoline-1-carbonyl)indolin-2-one | US12528797,...)
Affinity DataKd:  15nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369193BDBM369193(6-(2-Isopropylbenzimidazol-1-yl)-3H-1,3-benzothiaz...)
Affinity DataKd:  19nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369204BDBM369204(2-Oxo-N-phenyl-3H-oxazolo[4,5-b]pyridine-6-carboxa...)
Affinity DataKd:  24nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369200BDBM369200(6-(2,3-Dihydropyrrolo[2,3-b]pyridine-1-carbonyl)-3...)
Affinity DataKd:  24nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369202BDBM369202(6-(Indoline-1-carbonyl)-3H-1,3-benzothiazol-2-one ...)
Affinity DataKd:  28nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369210BDBM369210(N-(3,3-difluoro-2-oxo-indolin-5-yl)tetralin-1-carb...)
Affinity DataKd:  28nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369211BDBM369211(N-(3,3-Difluoro-1-oxo-indolin-5-yl)benzofuran-3-ca...)
Affinity DataKd:  52nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369197BDBM369197(2-Oxo-N-phenyl-3H-1,3-benzoxazole-6-carboxamide | ...)
Affinity DataKd:  54nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369201BDBM369201(2-Oxo-N-phenyl-3H-1,3-benzothiazole-6-carboxamide ...)
Affinity DataKd:  79nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369196BDBM369196(2-Oxo-N-phenylindoline-5-carboxamide | US12528797,...)
Affinity DataKd:  91nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 369195BDBM369195(6-(2-Isopropylbenzimidazol-1-yl)-3H-1,3-benzoxazol...)
Affinity DataKd:  108nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2026
Entry Details US Patent